GLYSCEND Trademark

Trademark Overview

On Thursday, May 13, 2021, a trademark application was filed for GLYSCEND with the United States Patent and Trademark Office. The USPTO has given the GLYSCEND trademark a serial number of 90708693. The federal status of this trademark filing is REGISTERED as of Tuesday, November 1, 2022. This trademark is owned by Glyscend, Inc.. The GLYSCEND trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of metabolic diseases including diabetes
glyscend

General Information

Serial Number90708693
Word MarkGLYSCEND
Filing DateThursday, May 13, 2021
Status700 - REGISTERED
Status DateTuesday, November 1, 2022
Registration Number6890734
Registration DateTuesday, November 1, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2022

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of metabolic diseases including diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 12, 2021
Primary Code005
First Use Anywhere DateWednesday, July 13, 2022
First Use In Commerce DateWednesday, July 13, 2022

Trademark Owner History

Party NameGlyscend, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLowell, MA 018543643
Party NameGlyscend, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLowell, MA 018543643
Party NameGlyscend, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLowell, MA 018543643

Trademark Events

Event DateEvent Description
Monday, May 17, 2021NEW APPLICATION ENTERED
Thursday, August 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 21, 2022ASSIGNED TO EXAMINER
Wednesday, January 26, 2022NON-FINAL ACTION WRITTEN
Wednesday, January 26, 2022NON-FINAL ACTION E-MAILED
Wednesday, January 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 29, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 29, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 25, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 14, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 14, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 29, 2022TEAS STATEMENT OF USE RECEIVED
Monday, September 12, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 29, 2022USE AMENDMENT FILED
Monday, September 12, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 29, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 30, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 1, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, November 1, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 2, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 2, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 2, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

glyscend including diabetes diseases metabolic preparations treatment pharmaceutical